Abstract

Gastric cancer (GC) bleeding is typically silent and chronic. However, active bleeding from GC can lead to life-threatening conditions. Endoscopic haemostasis is sometimes difficult and emergency surgery is associated with high postoperative complication rates. We encountered two cases of life-threatening GC haemorrhage. The patients were successfully treated with transcatheter arterial embolization and subsequent elective laparoscopic total gastrectomy. Preoperative embolization is effective for subsequent minimally invasive elective surgery in patients with severe bleeding from GC.

Introduction

Although gastric cancer (GC) bleeding is usually silent and chronic, unlike peptic ulcer bleeding, active bleeding may cause hypovolemic shock and life-threatening conditions. Therefore, prompt haemostasis is crucial for improving clinical outcomes [1]. Endoscopic haemostasis is regarded as the first-line treatment. However, gastroenterologists sometimes encounter endoscopic haemostasis failure [2, 3]. Although radical gastrectomy can be an ideal treatment approach for both curing GC and controlling bleeding [4], emergency gastrectomy is associated with high morbidity and mortality [5, 6]. Herein, we present two cases of life-threatening haemorrhages that were successfully treated with transcatheter arterial embolization (TAE) and subsequent elective laparoscopic total gastrectomy.

Case presentation

Patient 1

A 59-year-old man presented to the emergency department with loss of consciousness and hematemesis. His blood pressure was 90/50 mmHg. The patient’s haemoglobin level was 7.9 g/dL. The patient was haemodynamically unstable, and 12 units of red blood cell (RBC) concentrate were administered. Contrast-enhanced computed tomography (CT) revealed a gastric hyper-vascular mass on the lesser curvature (Fig. 1). Emergency upper gastrointestinal (GI) endoscopy performed under endotracheal intubation and ventilatory management revealed a large type 1 oozing tumour (Fig. 2a). Haemostatic procedures were not performed due to technical difficulties. Emergency angiography revealed a tumour stain from the left gastric artery, which was coil embolized (Fig. 3). Upper GI endoscopy 2 days later revealed no bleeding (Fig. 2b). After embolization, the patient became haemodynamically stable. It was later discovered that he had undergone open omental filling at another hospital 1 year prior due to GC perforation and left his disease untreated for a year at his own discretion. The patient received combination chemotherapy with S-1 and oxaliplatin, which was remarkably effective. Eight months after embolization, laparoscopic total gastrectomy with Roux-en-Y reconstruction and lymph node dissection were performed. The final histopathological diagnosis was T2N0M0 stage IB. Macroscopic findings revealed a type 1 tumour in the upper part of the stomach. Histopathological findings revealed that the tumour was a well-differentiated tubular adenocarcinoma. All surgical margins were negative. The patient had an uneventful postoperative course and was discharged 7 days after surgery. The patient was well, with no recurrence noted during the 35 months of follow-up.

Contrast-enhanced computed tomography image showing a gastric hyper vascular mass on the lesser curvature (arrow).
Figure 1

Contrast-enhanced computed tomography image showing a gastric hyper vascular mass on the lesser curvature (arrow).

Gastroscopic images; (a) endoscopy showing a large type 1 oozing tumour (arrow); (b) endoscopy after embolization showing no bleeding.
Figure 2

Gastroscopic images; (a) endoscopy showing a large type 1 oozing tumour (arrow); (b) endoscopy after embolization showing no bleeding.

Angiographic images; (a) the left gastric arteriography showing tumour staining (arrow); (b) the left gastric artery was coil embolized.
Figure 3

Angiographic images; (a) the left gastric arteriography showing tumour staining (arrow); (b) the left gastric artery was coil embolized.

Patient 2

A 78-year-old man was transferred to our hospital because of hypovolemic shock. He had already received 10 units of RBC concentrate. His blood pressure was 97/64 mmHg. The patient’s haemoglobin level was 8.2 g/dL. Contrast-enhanced CT showed active contrast extravasation in the stomach (Fig. 4). Emergency angiography revealed tumour staining in both the left and right gastroepiploic arteries, which were coil embolized (Fig. 5). Upper GI endoscopy 2 days later revealed a type 4 tumour without bleeding (Fig. 6). The patient was diagnosed with resectable GC, and underwent laparoscopic total gastrectomy with Roux-en-Y reconstruction and lymph node dissection. The final histopathological diagnosis was T4aN3aM0 stage IIIC. Macroscopic findings revealed a type 4 tumour of the stomach, and histopathological findings revealed that the tumour was a poorly differentiated adenocarcinoma with squamous cell differentiation. All surgical margins were negative. The patient developed a minor leakage that resolved spontaneously. The patient has remained recurrence-free for 12 months.

Contrast-enhanced computed tomography image showing active contrast extravasation in the stomach (arrow).
Figure 4

Contrast-enhanced computed tomography image showing active contrast extravasation in the stomach (arrow).

Angiographic images; the right (a) and left (b) gastroepiploic arteriograms showing tumour staining (arrows); (c) both arteries were coil embolized.
Figure 5

Angiographic images; the right (a) and left (b) gastroepiploic arteriograms showing tumour staining (arrows); (c) both arteries were coil embolized.

Endoscopy after embolization showing a type 4 tumour without bleeding.
Figure 6

Endoscopy after embolization showing a type 4 tumour without bleeding.

Discussion

Failed management of GC bleeding is associated with poor prognosis [1]. The American, European, and Japanese Guidelines for the diagnosis and management of non-variceal upper GI bleeding recommend early upper GI endoscopy and endoscopic therapy following prompt hemodynamic resuscitation [7–9]. However, gastroenterologists sometimes encounter endoscopic haemostasis failure in cases of GC bleeding [2, 3]. The technical success rate of endoscopic haemostasis for GC bleeding ranges from 83% to 100% [2, 10, 11]. The mean interval between initial haemostasis and recurrent bleeding is 6 days, and the rebleeding rate after initial endoscopic haemostasis ranges from 28.3% to 49% [10, 11]. The presence of large bleeding lesions (>2 cm) and non-exposed vessel bleeding with a tumour are significant predictive factors for endoscopic haemostasis failure [2]. Although radical gastrectomy can be an ideal treatment approach for both curing GC and controlling bleeding [4], surgeons face many challenges, including haemodynamic instability, insufficient oncologic work-up, and emergent surgery which are associated with a low curative resection rate and high rates of mortality and morbidity [5, 6]. TAE is mostly regarded as a second-line treatment after endoscopic haemostasis failure. The technical and clinical success rates of TAE in patients with GC bleeding are 85.0%–100% and 40%–72.5%, respectively [12–14]. The clinical success rate of TAE for tumour staining is high [12]. Considering the effectiveness of TAE for tumour staining and the difficulty of endoscopic haemostasis in large tumours, it may have been reasonable to perform TAE in our cases because delayed TAE after endoscopic haemostasis failure can also have a worse prognosis than TAE performed earlier after only diagnostic endoscopy [13]. We report that preoperative embolization is effective for subsequent elective surgery in patients with severe neoplasm bleeding [15]. According to the National Clinical Database, a nationwide surgery registration system in Japan, minimally invasive procedures are less frequent in emergency gastrectomies [5]. In the present cases, we successfully performed laparoscopic total gastrectomy with curative resection as an elective surgery.

Conclusion

Despite our limited experience, and the need for future studies to establish the appropriate indications, preoperative TAE may serve as a bridge to curative and minimally invasive surgery, thereby reducing the need for emergency surgery, which is associated with high postoperative complication rates, in patients with potentially resectable GC. However, the benefits of this approach require further validation and, understanding of the importance of careful patient selection for successful treatment.

Conflict of interest statement

None declared.

Funding

None declared.

References

1.

Kawabata
 
H
,
Hitomi
 
M
,
Motoi
 
S
.
Management of bleeding from unresectable gastric cancer
.
Biomedicine
 
2019
;
7
:
54
. .

2.

Park
 
H
,
Ahn
 
JY
,
Jung
 
HY
, et al.  
Can endoscopic bleeding control improve the prognosis of advanced gastric cancer patients?: a retrospective case-control study
.
J Clin Gastroenterol
 
2017
;
51
:
599
606
. .

3.

Koh
 
KH
,
Kim
 
K
,
Kwon
 
DH
, et al.  
The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer
.
Gastric Cancer
 
2013
;
16
:
397
403
. .

4.

Wang
 
L
,
Wang
 
XA
,
Hao
 
JQ
, et al.  
Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding
.
World J Gastroentel
 
2015
;
21
:
13316
24
.

5.

Hoshino
 
N
,
Endo
 
H
,
Hida
 
K
, et al.  
Emergency surgery for gastrointestinal cancer: a nationwide study in Japan based on the National Clinical Database
.
Ann Gastroenterol Surg
 
2020
;
4
:
549
61
. .

6.

So
 
JBY
,
Yam
 
A
,
Cheah
 
WK
, et al.  
Risk factors related to operative mortality and morbidity in patients undergoing emergency gastrectomy
.
Br J Surg
 
2000
;
87
:
1702
7
.

7.

Fujishiro
 
M
,
Iguchi
 
M
,
Kakushima
 
N
, et al.  
Guidelines for endoscopic management of non-variceal upper gastrointestinal bleeding
.
Dig Endosc
 
2016
;
28
:
363
78
. .

8.

Laine
 
L
,
Barkun
 
AN
,
Saltzman
 
JR
, et al.  
ACG clinical guideline: upper gastrointestinal and ulcer bleeding
.
Am J Gastroenterol
 
2021
;
116
:
899
917
. .

9.

Triantafyllou
 
K
,
Gkolfakis
 
P
,
Gralnek
 
IM
, et al.  
Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) guideline
.
Endoscopy
 
2021
;
53
:
850
68
. .

10.

Sheibani
 
S
,
Kim
 
JJ
,
Chen
 
B
, et al.  
Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy
.
Aliment Pharmacol Ther
 
2013
;
38
:
144
50
. .

11.

Kim
 
YI
,
Choi
 
IJ
,
Cho
 
SJ
, et al.  
Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer
.
J Gastroenterol Hepatol
 
2013
;
28
:
1489
395
. .

12.

Park
 
S
,
Shin
 
JH
,
Gwon
 
DI
, et al.  
Transcatheter arterial embolization for gastrointestinal bleeding associated with gastric carcinoma: prognostic factors predicting successful hemostasis and survival
.
J Vasc Interv Radiol
 
2017
;
28
:
1012
21
. .

13.

Lee
 
HJ
,
Shin
 
JH
,
Yoon
 
HK
, et al.  
Transcatheter arterial embolization in gastric cancer patients with acute bleeding
.
Eur Radiol
 
2009
;
19
:
960
5
. .

14.

Cho
 
SB
,
Hur
 
S
,
Kim
 
HC
, et al.  
Transcatheter arterial embolization for advanced gastric cancer bleeding. A single-center experience with 58 patients
.
Medicine
 
2020
;
99
:
e19630
. .

15.

Tanemura
 
M
,
Cho
 
A
,
Niwa
 
Y
, et al.  
Successful embolization with subsequent pancreaticoduodenectomy for intraductal papillary mucinous neoplasm hemorrhage: a case report and review of literature
.
Clin J Gastroenterol
 
2024
;
17
:
1118
24
. .

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.